Small Business Innovation Research · Small Business Technology Transfer
Lynntech Inc.: SBIR & STTR awards
206 awards worth $60.80M to 1 companies since 1989 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
Lynntech Inc.'s federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2025 | 1 | 0 | $600.0K |
| 2024 | 4 | 0 | $1.17M |
| 2023 | 4 | 0 | $1.21M |
| 2021 | 2 | 1 | $2.06M |
| 2020 | 4 | 2 | $3.56M |
| 2019 | 3 | 0 | $664.7K |
| 2018 | 7 | 0 | $1.61M |
| 2017 | 0 | 1 | $1000.0K |
| 2016 | 4 | 2 | $3.19M |
| 2015 | 7 | 0 | $1.58M |
| 2014 | 4 | 1 | $2.28M |
| 2013 | 4 | 2 | $3.12M |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| B-SMART - BROADLY NEUTRALIZING ANTIBODIES FOR SARNA MEDIATED ANTIVIRAL RESPONSE THERAPY · topic 137 | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $600.0K | 2025 |
| Make an OFERR: Optimization for Enhanced RNA Replication · topic 400 | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $283.3K | 2024-09-19 |
| Cutaneous Gel Delivering an Intriguing MOA Therapeutic to Treat DFU · topic NIDDK | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $343.7K | 2024-09-01 |
| CORNAUCOPIA - A METHOD TO DELIVER MULTIPLE BNABS IN THE SAME RNA · topic 124 | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $300.0K | 2024 |
| Phase I_LynntechInc_NCHHSTP_Topic_056 · topic CDC/NCHHSTP 056 | Lynntech Inc. · Texas | Department of Health and Human Services · Centers for Disease Control and Prevention | SBIR Phase I | $242.5K | 2024 |
| An Isothermal Method to Amplify RNA from Bloodborne Viruses · topic NIAID | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $290.2K | 2023-08-01 |
| DEVELOPMENT OF AUTOMATED CELL CULTURE FLASK CLEANING INSTRUMENT LYNNTECH INC:1109527 [23-004993] · topic 23 | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $324.9K | 2023 |
| RAPID POINT-OF-CARE HIV VIRAL LOAD TEST · topic 114 | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $300.0K | 2023 |
| DESIGN AND DEVELOP A NOVEL APPROACH TERMED 3IN1 TO EFFICIENTLY COLLECT SAMPLES IN FIELD LOCATIONS (BLOOD SPUTUM URINE) TO SUPPORT SURVEILLANCE ACTIVITIES TO IDENTIFY NEW VIRUSES OF PANDEMIC POTENTIAL · topic 120 | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $299.3K | 2023 |
| Point-of-care diagnostic for amplification and detection of SARS-CoV-2 RNA · topic NIAID | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $256.6K | 2021-07-02 |
| iCAP An Innovative Device to Rapidly Resolve Microbial Keratitis · topic NEI | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.56M | 2021-06-01 |
| Development of Self-Detoxifying Filter Media for Active Decontamination · topic NIAID | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $250.8K | 2020-12-11 |
| iKITT Innovative Keratitis Identity Type Test · topic Y | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $310.9K | 2020-09-30 |
| Rapid POC diagnostic for Candida species and multidrug resistance identification · topic NCEZID | Lynntech Inc. · Texas | Department of Health and Human Services · Centers for Disease Control and Prevention | SBIR Phase I | $224.8K | 2020-09-01 |
| Development of a dengue exposure monitor · topic NIAID | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $244.4K | 2020-08-01 |
| Development of a Simple Diagnostic for Causative Agents of Schistosomiasis · topic NIAID | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $241.5K | 2020-05-08 |
| Rapid Test Kit for Measurement of Urinary Iodine · topic NICHD | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.04M | 2020-02-01 |
| THIS IS AN SBIR PHASE II CONTRACT: SUBSTRATE ALTERNATIVES FOR ORGAN-ON-A-CHIPS. · topic 18 | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.50M | 2020 |
| Rapid electrochemical detection of arsenic in water · topic NIEHS | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $196.0K | 2019-09-20 |
| Rapid Simple Antimicrobial Determination and POC Diagnostic for Gonorrhea · topic NIAID | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $243.7K | 2019-07-01 |
| NCATS SBIR 2019 PHASE I PROPOSALS TOPIC 018 ENTITLED NON-PDMS BIOCOMPATIBLE ALTERNATIVES FOR ORGANS-ON-CHIPS · topic NIDA | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $225.0K | 2019 |
| Next Generation All Solid State NASS Lithium Batteries for Implantable Devices · topic R | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $228.8K | 2018-09-21 |
| Continuous removal/disposal system for the concurrent sorption and breakdown of contaminants into harmless precipitates · topic NIEHS | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $225.0K | 2018-09-18 |
| Lightweight and long lasting battery technology for Left Ventricular Assist Devices LVADs · topic NHLBI | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $216.7K | 2018-09-15 |
| An Inhaled Clofazimine Formulation for the Treatment of Tuberculosis · topic NIAID | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $384.4K | 2018-06-15 |
| Rapid Test Kit for Measurement of Urinary Iodine · topic NICHD | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $150.9K | 2018-05-01 |
| VR Grip - hand Peripheral for Improved Resident Training in Surgical Simulations · topic 300 | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $258.9K | 2018-04-01 |
| Development of Taenia Solium Specific Aptamers for Diagnostic Assays · topic ODCDC | Lynntech Inc. · Texas | Department of Health and Human Services · Centers for Disease Control and Prevention | SBIR Phase I | $149.9K | 2018 |
| Multiplex Detection of MDROs and Lower Intestinal Microbiome Disruption · topic ODCDC | Lynntech Inc. · Texas | Department of Health and Human Services · Centers for Disease Control and Prevention | SBIR Phase II | $1000.0K | 2017 |
| Enhanced Non Fouling Membranes for Water Purification and Recycling · topic NIEHS | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $805.4K | 2016-09-30 |
| iCAP An Innovative Device to Rapidly Resolve Microbial Keratitis · topic N | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $236.5K | 2016-09-30 |
| One-Step, POC Sample-to-Answer Process for RNA Analysis Outside the Laboratory · topic 200 | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase II | $1.47M | 2016-09-23 |
| A Non Toxic solution to develop next generation of insecticidal bed nets · topic NIAID | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $231.1K | 2016-08-01 |
| SNAPCAP A Novel Chronic Wound Management Device · topic 200 | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $294.0K | 2016-05-10 |
| Multiplex Detection of MDROs and Lower Intestinal Microbiome Distruption · topic ODCDC | Lynntech Inc. · Texas | Department of Health and Human Services · Centers for Disease Control and Prevention | SBIR Phase I | $150.0K | 2016 |
| Biocompatible retinal prosthesis based on a conjugated polymer photoactive layer · topic N | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $310.2K | 2015-09-30 |
| NEOSAFE Novel material for manufacturing of neonatal devices via 3D Printing · topic NICHD | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $225.0K | 2015-09-18 |
| Wearable Device to Monitor Blood Alcohol Levels in Real Time · topic 450 | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $225.0K | 2015-09-15 |
| Rapid detection of arsenic in water · topic NIEHS | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $150.0K | 2015-05-01 |
| IGF OT IGF Asymmetric Convectional PCR Coupled with Silicon Nanowires to Detect Rare Genetic Mutations · topic NCI | Lynntech Inc. · Texas | Department of Health and Human Services · National Institutes of Health | SBIR Phase I | $300.0K | 2015 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.